High-risk human papillomavirus types in HIV-infected and HIV-uninfected young women in KwaZulu-Natal, South Africa: implications for vaccination

References

• De Villiers EM. Taxonomic classification of papillomaviruses. Papillomavirus Rep. 2001;12:57–63.
   Google Scholar
• Muñoz N , Bosch FX , De Sanjosé S , et al . Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003;348:518–527.
   PubMed Web of Science ®Google Scholar
• Bosch F , Lorincz A , Munoz N , et al . The causal relation between human papillomavirus and cervical cancer. J Clin Pathol. 2002;55:244–265.
   PubMed Web of Science ®Google Scholar
• Ferlay J , Soerjomataram I , Dikshit R , et al . GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 11. Lyon, France: IARC; 2013. [cited 2017 Feb 20]. Available from: http://globocan.iarc.fr
   Google Scholar
• Moscicki AB , Ellenberg JH , Farhat S , et al . Persistence of human papillomavirus infection in HIV-infected and -uninfected adolescent girls: risk factors and differences, by phylogenetic type . J Infect Dis. 2004;190:37–45.
   PubMed Web of Science ®Google Scholar
• Moscicki AB , Ma Y , Wibbelsman C , et al . Rate of and risks for regression of cervical intraepithelial neoplasia 2 in adolescents and young women. Obstet Gynecol. 2010;116:1373.
   PubMed Web of Science ®Google Scholar
• International Agency for Research on Cancer . 2012. Biological agents: a review of human carcinogens. Lyon, France. [cited 2017 Mar 04]. Available from: http://monographs.iarc.fr/ENG/Monographs/vol100B/mono100B.pdf
   Google Scholar
• Li N , Franceschi S , Howell , ‐et al . Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: variation by geographical region, histological type and year of publication. Int J Cancer. 2011;128:927–935.
   PubMed Web of Science ®Google Scholar
• Clifford G , Smith J , Aguado T , et al . Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis. Br J Cancer. 2003;89:101–105.
   PubMed Web of Science ®Google Scholar
• de Sanjose S , Quint WG , Alemany L , et al . Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol. 2010;11:1048–1056.
   PubMed Web of Science ®Google Scholar
• World Health Organization . 2014. Human Papillomavirus vaccines: WHO position paper. [cited 2017 Feb]. Available from: http://www.who.int/wer/2014/wer8943.pdf?ua=1
   Google Scholar
• Smith JS , Lindsay L , Hoots B , et al . Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer. 2007;121:621–632.
   PubMed Web of Science ®Google Scholar
• Clifford G , Franceschi S , Diaz M , et al . HPV type-distribution in women with and without cervical neoplastic diseases. Vaccine. 2006;24:S26–S34.
   Web of Science ®Google Scholar
• Clifford GM , Gallus S , Herrero R , et al . Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet. 2005;366:991–998.
   PubMed Web of Science ®Google Scholar
• World Health Organization . GLOBOCAN 2012: Estimated cancer incidence, mortality and prevalence worldwide in 2012 [online]. Lyon, France: International Agency for Research on Cancer; 2014. Available from: http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx.
   Google Scholar
• Arbyn M , Castellsague X , de Sanjose S , et al . Worldwide burden of cervical cancer in 2008. Ann Oncol. 2011;22:2675–2686.
   PubMed Web of Science ®Google Scholar
• International Agency for Research in Cancer . Latest world cancer statistics 2013 [cited 2014]. Available from: http://www.iarc.fr/en/media-centre/pr/2013/pdfs/pr223_E.pdf.
   Google Scholar
• Adar J , Stevens M. Women’s health. In: Ntuli A , editor. South African Health Review 2000. Durban: Health Systems Trust; 2000. p. 411–428.
   Google Scholar
• Denny L. Human papillomavirus infection: epidemiology, clinical aspects and vaccines. TOIDJ. 2009;3:135–142.
   Google Scholar
• Ahdieh L , Klein RS , Burk R , et al . Prevalence, incidence, and type-specific persistence of human papillomavirus in human immunodeficiency virus (HIV)-positive and HIV-negative women. J Infect Dis. 2001;184:682.
   PubMed Web of Science ®Google Scholar
• Munoz N , Bosch FX , Castellsagué X , et al . Against which human papillomavirus types shall we vaccinate and screen? The international perspective. Int J Cancer. 2004;111:278–285.
   PubMed Web of Science ®Google Scholar
• Bryan JT. Developing an HPV vaccine to prevent cervical cancer and genital warts. Vaccine. 2007;25:3001–3006.
   PubMed Web of Science ®Google Scholar
• Release FN. FDA approves Gardasil 9 for prevention of certain cancers caused by five additional types of HPV 2014. 2014. Available from: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm426485.htm.
   Google Scholar
• Bosch FX , Broker TR , Forman D , et al . Comprehensive control of human papillomavirus infections and related diseases. Vaccine. 2013;31:H1–H31.
   PubMed Web of Science ®Google Scholar
• Rand Water . Water wise-water situation in South Africa 2015. 2015. Available from: http://www.waterwise.co.za/site/water/environment/situation.html.
   Google Scholar
• de Roda Husman AM , Walboomers JMM , van den Brule AJC , et al . The use of general primers GP5 and GP6 elongated at their 3′ ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J Gen Virol. 1995;76:1057–1062.
   PubMed Web of Science ®Google Scholar
• Jacobs MV , Snijders P , Van Den Brule A , et al . A general primer GP5+/GP6 (+)-mediated PCR-enzyme immunoassay method for rapid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes in cervical scrapings. J Clin Microbiol. 1997;35:791–795.
   PubMed Web of Science ®Google Scholar
• Smith JS , Melendy A , Rana RK , et al . Age-specific prevalence of infection with human papillomavirus in females: a global review. J Adolesc Health. 2008;43:S5–S5.e62.
   PubMed Web of Science ®Google Scholar
• Ebrahim S , Mndende X , Kharsany ABM , et al . High burden of human papillomavirus (HPV) ingfection among young women in KwaZulu-Natal, South Africa. PLoS One. 2016;11:10.
   Web of Science ®Google Scholar
• Allan B , Marais DJ , Hoffman M , et al . Cervical human papillomavirus (HPV) infection in South African women: implications for HPV screening and vaccine strategies. J Clin Microbiol. 2008;46:740–742.
   PubMed Web of Science ®Google Scholar
• McDonald AC , Denny L , Wang C , et al . Distribution of high-risk human papillomavirus genotypes among HIV-negative women with and without cervical intraepithelial neoplasia in South Africa. PLoS One. 2012;7:e44332.
   PubMed Web of Science ®Google Scholar
• Richter K , Becker P , Horton A , et al . Age-specific prevalence of cervical human papillomavirus infection and cytological abnormalities in women in Gauteng Province, South Africa. S Afr Med J. 2013;103:313–317.
   PubMed Web of Science ®Google Scholar
• Said HM , Ahmed K , Burnett R , et al . HPV genotypes in women with squamous intraepithelial lesions and normal cervixes participating in a community-based microbicide study in Pretoria, South Africa. J Clin Virol. 2009;44:318–321.
   PubMed Web of Science ®Google Scholar
• Baay MFD , Kjetland EF , Ndhlovu PD , et al . Human papillomavirus in a rural community in Zimbabwe: the impact of HIV co‐infection on HPV genotype distribution. J Med Virol. 2004;73:481–485.
   PubMed Web of Science ®Google Scholar
• Dartell M , Rasch V , Kahesa C , et al . Human papillomavirus prevalence and type distribution in 3603 HIV-positive and HIV-negative women in the general population of Tanzania: the PROTECT study. Sex Transm Dis. 2012;39:201–208.
   PubMed Web of Science ®Google Scholar
• Beachler DC , Weber KM , Margolick JB , et al . Risk factors for oral HPV infection among a high prevalence population of HIV-positive and at-risk HIV-negative adults. Cancer Epidemiol Biomarkers Prev. 2012;21:122–133.
   PubMed Web of Science ®Google Scholar
• Van Aar F , Mooij SH , Van Der Sande MA , et al . Anal and penile high-risk human papillomavirus prevalence in HIV-negative and HIV-infected MSM. AIDS. 2013;27:2921–2931.
   PubMed Web of Science ®Google Scholar
• Banura C , Franceschi S , van Doorn LJ , et al . Infection with human papillomavirus and HIV among young women in Kampala, Uganda. J Infect Dis. 2008;197:555
   PubMed Web of Science ®Google Scholar
• Bruni L , Diaz M , Castellsagué M , et al . Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. J Infect Dis. 2010;202:1789–1799.
   PubMed Web of Science ®Google Scholar
• Garland SM , Kjaer SK , Muñoz N , et al . Impact and effectiveness of the quadrivalent human papillomavirus vaccine: a systematic review of ten years of real-world experience. Clin Infect Dis. 2016;356:ciw354.
   Google Scholar
• Guan P , Howell ‐Jones R , et al . Human papillomavirus types in 115,789 HPV-positive women: a meta-analysis from cervical infection to cancer. Int J Cancer. 2012;131:2349–2359.
   PubMed Web of Science ®Google Scholar
• Serrano B , Alemany L , Tous S , et al . Potential impact of a nine-valent vaccine in human papillomavirus related cervical disease. Infect Agents Cancer. 2012;7:38.
   PubMed Web of Science ®Google Scholar
• Forman D , de Martel C , Lacey CJ , et al . Global burden of human papillomavirus and related diseases. Vaccine. 2012;30:F12–F23.
   PubMed Web of Science ®Google Scholar